Showing results (181-190 of 336) with videos related to
Sort By:
Pageof 34
Lung Cancer (Amsterdam, Netherlands)|February 25, 2021
Dose-dependence in acquisition of drug tolerant phenotype and high RYK expression as a mechanism of osimertinib tolerance in lung cancerShuta Ohara, Kenichi Suda, Toshio Fujino, et al.Lung Cancer (Amsterdam, Netherlands)|April 3, 2013
Efficacy and safety of weekly nab-paclitaxel plus carboplatin in patients with advanced non-small cell lung cancerMiyako Satouchi, Isamu Okamoto, Hiroshi Sakai, et al.Lung Cancer (Amsterdam, Netherlands)|December 12, 2018
Effects of secondary EGFR mutations on resistance against upfront osimertinib in cells with EGFR-activating mutations in vitroMasaya Nishino, Kenichi Suda, Yoshihisa Kobayashi, et al.Cancers|May 13, 2023
Performance of Ultra-Rapid Idylla™ EGFR Mutation Test in Non-Small-Cell Lung Cancer and Its Potential at Clinical Molecular ScreeningKenichi Suda, Kazuko Sakai, Tatsuo Ohira, et al.Lung Cancer (Amsterdam, Netherlands)|June 19, 2014
CRKL amplification is rare as a mechanism for acquired resistance to kinase inhibitors in lung cancers with epidermal growth factor receptor mutationKenichi Suda, Hiroshi Mizuuchi, Isao Murakami, et al.Scientific Reports|September 25, 2015
Small cell lung cancer transformation and T790M mutation: complimentary roles in acquired resistance to kinase inhibitors in lung cancerKenichi Suda, Isao Murakami, Kazuko Sakai, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 7, 2019
Sensitivity and Resistance of MET Exon 14 Mutations in Lung Cancer to Eight MET Tyrosine Kinase Inhibitors In VitroToshio Fujino, Yoshihisa Kobayashi, Kenichi Suda, et al.Cancer Science|April 12, 2019
Performance of Oncomine Fusion Transcript kit for formalin-fixed, paraffin-embedded lung cancer specimensKazuko Sakai, Tatsuo Ohira, Jun Matsubayashi, et al.Neuro-Oncology|March 3, 2006
EGFR mutations in patients with brain metastases from lung cancer: association with the efficacy of gefitinibShinji Shimato, Tetsuya Mitsudomi, Takayuki Kosaka, et al.Cancer Science|February 23, 2005
Reduced expression of Dicer associated with poor prognosis in lung cancer patientsYoko Karube, Hisaaki Tanaka, Hirotaka Osada, et al.Pageof 34